SS
INBX

Steve Schonfeld’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Steve Schonfeld’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-89,330
Closed -$3.39M – 2546
2023
Q4 		$3.39M Buy
+89,330
New +$1.91M 0.02% 629

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Steve Schonfeld's INBX Position: Q1 2024 in Review

Steve Schonfeld sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2024, closing a stake of 89,330 shares — an estimated $3.39M sold.

Steve Schonfeld first reported a position in INBX in Q4 2023 and held it in 1 quarter. The position peaked at $3.39M in Q4 2023. 126 funds tracked by Wall St. Rank hold INBX as of Q1 2024.

  • Steve Schonfeld reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Steve Schonfeld sold 89,330 Inhibrx, Inc. Common Stock shares in Q1 2024, an estimated $3.39M.
  • Steve Schonfeld first reported a position in Inhibrx, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Steve Schonfeld's Inhibrx, Inc. Common Stock position peaked at $3.39M in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.